Polymeric micelles for drug delivery

Current Pharmaceutical Design

Volumn 12, Issue 36, 2006, Pages 4669-4684

  Croy, S R ^a   Kwon, G S ^b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NONE   (United States)

Author keywords

Block copolymers; Drug delivery; Physical Characterization; Poloxamers; Poly(ethylene glycol); Polymeric micelles; Solubilization

Indexed keywords

AMPHOPHILE; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; CLONAZEPAM; COPOLYMER; DOXORUBICIN; FENOFIBRATE; INDOMETACIN; MACROGOL; METHOTREXATE; NYSTATIN; PACLITAXEL; POLOXAMER; POLY(2 HYDROXYALKYL LEVO ASPARTAMIDE); POLY(BETA BENZYL LEVO ASPARTATE); POLY(BETA BENZYL LEVO GLUTAMATE); POLY(N ISOPROPYLACRYLAMIDE); POLY(PROPYLENE OXIDE); POLYASPARTIC ACID; POLYCAPROLACTONE; POLYESTER; POLYLACTIDE; POLYMER; POLYMETHACRYLIC ACID; PROPOFOL; VINBLASTINE;

BONE MARROW SUPPRESSION; CANDIDIASIS; CHEMICAL STRUCTURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ACCUMULATION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG METABOLISM; DRUG RESEARCH; DRUG SOLUBILITY; ENCAPSULATION; HUMAN; HYDRODYNAMICS; MATHEMATICAL COMPUTING; MICELLE; MICELLIZATION; MOLECULAR DYNAMICS; MOLECULAR SIZE; MOLECULAR STABILITY; NANOPARTICLE; NEUTROPENIA; NONHUMAN; PHYSICAL CHEMISTRY; POLYNEUROPATHY; PRIORITY JOURNAL; SOLID TUMOR; SOLUBILIZATION; SUSTAINED DRUG RELEASE; VISCOSITY;

AMINO ACIDS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; MICELLES; MOLECULAR CONFORMATION; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; POLOXAMER; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS; PROPYLENE GLYCOLS; SOLUBILITY; SURFACE PROPERTIES;

EID: 33751512735     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206779026245     Document Type: Conference Paper

References (157)

1. Lipinski CA. Avoiding investment in doomed drugs, is poor solubility an industry wide problem?. Curr Drug Dis 2001; 1: 17-9.
2. Lipinski C. Poor aqueous solubility - an industry wide problem in drug discovery. Am Pharm Rev 2002; 5: 82-5.
3. Technology Catalysts International, Drug delivery technologies for poorly-soluble drugs second edition, Technology Catalysts International Corporation, Falls Church, VA, August 2004.
4. Strickley RG. Parenteral formulations of small molecules therapeutics marketed in the United States: part I. PDA J Pharm Sci Tech 1999; 53: 324-49.
5. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004; 21: 201-30.
6. Fiese EF. General pharmaceutics: the new physical pharmacy. J Pharm Sci 2003; 92: 1331-42.
7. Jonkman-de Vries JD, Flora KP, Bult A, Beijnen JH. Pharmaceutical development of (investigational) anticancer agents for parenteral use: a review. Drug Dev Industrial Pharm 1996; 22: 475-94.
8. Alade SL, Brown RE, Paquet A. Polysorbate 80 and E-Ferol toxicity. Pediatrics 1986; 77: 593-7.
9. Varma RK, Kaushal R, Junnarkar AY, Thomas GP, Naidu MUR, Singh PP, et al. Polysorbate 80: a pharmacological study. Arzneimittelforschung 1985; 35: 804-8.
10. ten Tije AJ, Verweij J, Loos WJ, Sparreboom A. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin Pharmacokinet 2003; 42: 665-85.
11. Astafieva I, Zhong X, Eisenberg A. Critical micellization phenomena in block polyelectrolyte solutions. Macromolecules 1993; 26: 7339-52.
12. Price C. Micelle formation by block copolymer in organic solvents. Pure and Appl Chem 1983; 55: 1563-72.
13. Chu B, Zhou Z. In: Nace VM Ed, Nonionic Surfactants: polyoxyalkylene block copolymers, volume 60, New York, Marcel Dekker, Inc 1996; 67-143.
14. Kralchevsky PA, Danov KD, Denkov ND. In: Birdi KS Ed, Handbook of surface and colloid chemistry, second edition, Boca Raton, CRC Press 2003; 137-344.
15. Fisicaro E, Pelizzetti E. Thermodynamics of surfactant solutions and hydrophobic effect. Trends Phys Chem 1994; 4: 1-14.
16. Mesa CL, Coppola L, Pogliani L, Ranieri GA, Terenzi M, Sesta B. Organized surfactant assemblies dynamics and thermodynamics. Trends Phys Chem 1994; 4: 15-27.
17. Kwon G, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Micelles based on ab block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartate). Langmuir 1993; 9: 945-9.
18. Kim SY, Shin IG, Lee YM, Cho CS, Sung YK. Methoxypoly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin, II. Micelle formation and drug release behaviors. J Control Release 1998; 51: 13-22.
19. Kabanov AV, Alakhov VY. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug 2002; 19: 1-73.
20. Myers D. Association colloids: Micelles, vesicles, and membranes. In: Myers D, Ed, Surfaces, interfaces, and colloids: Principles and applications, second edition, New York, John Wiley & Sons, 1999; 383.
21. Goon P, Manohar C, Kumar VV. Determination of critical micelles concentration of anionic surfactants: Comparison of internal and external fluorescent probes. J Colloid Interface Sci 1997; 189: 177-80.
22. Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug 2003; 20: 357-403.
23. Batrakova EV, Li S, Venne A, Alakhov V, Kabanov A. Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 1999; 16: 1373-9.
24. Alexandridis P, Holzwarth JF, Hatton TA. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association. Macromolecules 1994; 27: 2414-25.
25. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y, et al. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release 1998; 50: 79-92.
26. Rakshit AK, Palepu RM. Additive effects on nonionic surfactant molecular assemblies: a review. Recent Dev Coll Interface Res 2003; 1: 203-19.
27. Nagarajan R. Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-PPOPEO) block copolymers. Coll Surfaces B Biointerf 1999; 16: 55-72.
28. Xing L, Mattice WL. Strong solubilization of small molecules by triblock-copolymer micelles in selective solvents. Macromolecules 1997; 30: 1711.
29. Mata J, Joshi T, Varade D, Ghosh G, Bahadur P. Aggregation behavior of a PEO-PPO-PEO block copolymer + ionic surfactants mixed systems in water and aqueous salt solutions. Coll Surf A 2004; 247: 1-7.
30. Alexandridis P, Athanassiou V, Fukuda S, Hatton TA. Surface activity of poly(ethylene oxide)-block-poly(propylene oxide)-block-poly(ethylene oxide) copolymers. Langmuir 1994; 10: 2604-12.
31. Chu B. Laser light scattering. Basic principles and practice, second edition, New York, Academic Press, 1991.
32. Zana R. Fluorescence studies of amphiphilic block copolymers in solution. In: Alexandridis P, Lindman B Eds, Amphiphilic block copolymers: self assembly and applications. Amsterdam, Elsevier, 2000; 191-220.
33. Jada A, Siffert B, Reiss G. Adsorption at the solid-solution interface and micelle formation in water of a PEO-PS-PEO triblock copolymer. Colloids Surf A 1993; 75: 203-9.
34. Winnik FM, Regismond STA. Fluorescence methods in the study of the interactions of surfactants with polymers. Colloids Surf A 1996; 118: 1-39.
35. Patist A, Bhagwat SS, Penfield KW, Aikens P, Shah DO. On the measurement of critical micelle concentrations of pure and technical-grade nonionic surfactants. J Surfactants Deterg 2000; 3: 53-8.
36. Chaibundit C, Ricardo NMPS, Crothers M, Booth C. Micellization of diblock(oxyethylene/oxybutylene) copolymer E11B8 in aqueous solution. Micelle size and shape. Drug solubilization. Langmuir 2002; 18: 4277-83.
37. Schillen K, Glatter O, Brown W. Characterization of a PEO-PPO-PEO block copolymer system. Prog Coll Pol Sci 1993; 93: 66-71.
38. Majhi PR, Blume A. Thermodynamic characterization of temperature-induced micellization and demicellization of detergents studied by differential scanning calorimetry. Langmuir 2001; 17: 3844-51.
39. Alexandridis P, Holzwarth JF. Differential scanning calorimetry investigation of the effect of salts on aqueous solution properties of an amphiphilic block copolymer (poloxamer). Langmuir 1997; 13: 6074-82.
40. Kaya H, Willner L, Allgaier J, Stellbrink J, Richter D. Micellization of symmetric PEP-PEO block copolymers in water: Molecular weight dependence. Appl Phys A 2002; 74(Suppl. Pt. 1): S499-S501.
41. Brown GS, Moncton DE, Eds. Handbook on synchrotron radiation, volume three, Amsterdam, North Holland 1991; 379-469.
42. Glatter O, Kratky O, Eds. Small angle x-ray scattering, New York, Academic Press, 1982.
43. Hansson P, Joensson B, Stroem C, Soederman O. Determination of micellar aggregation numbers in dilute surfactant systems with the fluorescence quenching method. J Phys Chem B 2000; 104: 3496-3506.
44. Alargova RG, Kochijashky II, Sierra ML, Zana R. Micelle aggregation numbers of surfactants in aqueous solutions: A comparison between the results from steady-state and time-resolved fluorescence quenching. Langmuir 1998; 14: 5412-8.
45. Esselink FJ, Dormidontova E, Hadziioannou G. Evolution of block copolymer micellar size and structure evidenced by cryo electron microscopy. Macromolecules 1998; 31: 2925-32.
46. Lam YM, Grigorieff N, Goldbeck-Wood G. Direct visualization of micelles of Pluronic block copolymers in aqueous solution by cryo-TEM. Phys Chem Chem Phys 1999; 1: 3331-3.
47. Riess G. Micellization of block copolymers. Prog Polym Sci 2003; 28: 1107-70.
48. Goldraich M, Talmon Y. Direct-imaging cryo-transmission electron microscopy in the study of colloids and polymer solutions. In: Alexandridis P, Lindman B, Eds. Amphiphilic block copolymers: self assembly and applications. Amsterdam, Elsevier 2000; 253-80.
49. Kohori K, Sakai K, Aoyagi T, Yokoyama M, Sakurai Y, Okano T. Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). J Control Release 1998; 55: 87-98.
50. Allemann E, Leroux JC, Gurny R. Biodegradable nanoparticles of poly(lactic acid) and poly(lactic-co-glycolic acid) for parenteral administration. In: Lieberman H, Rieger M, Banker G Eds, Pharmaceutical dosage forms: Disperse systems, volume three, New York, Marcel Dekker, 1998; 163-93.
51. Cammas S, Suzuki K, Sone C, Sakurai Y, Kataoka K, Okano T. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J Control Release 1997; 48: 157-64.
52. D'Errico G, Ciccarelli D, Ortona O, Vitagliano V. Mixed micellar aggregates of nonionic surfactants with short hydrophobic trails. J Mol Liq 2002; 100: 241-53.
53. Higgins JS, Benoit HC. Polymers and neutron scattering, New York, Oxford University Press Inc., 1994.
54. Zana R. Microviscosity of aqueous surfactant micelles: Effect of various parameters. J Phys Chem B 1999; 103: 9117-25.
55. Yamamoto Y, Yasugi K, Harada A, Nagasaki Y, Kataoka K. Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles in aqueous milieu. J Control Release 2002; 82: 359-71.
56. Croy SR, Kwon GS. The effects of Pluronic block copolymers on the aggregation state of nystatin. J Control Release 2004; 95: 161-71.
57. Heimenz PC, Rajagopalan R. Principles of Colloid and Surface Chemistry, Third Edition, New York, Marcel Dekker, 1997.
58. Zhang L, Eisenberg A. Thermodynamic vs kinetic aspects in the formation and morphological transitions of crew-cut aggregates produced by self-assembly of polystyrene-b-poly(acrylic acid) block copolymers in dilute solution. Macromolecules 1999; 32: 2239-49.
59. Wanka G, Hoffman H, Ulbricht W. Phase diagrams and aggregation behavior of poly(oxyethylene)-poly(oxypropylene)-poly(oxyethylene) triblock copolymers in aqueous solutions. Macromolecules 1994; 27: 4145-59.
60. Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B 1999; 16: 3-27.
61. Linse, P. Micellization of poly(ethylene oxide)-poly(propylene oxide) block copolymers in aqueous solution. Macromolecules 1993; 26: 4437-49.
62. La SB, Okano T, Kataoka K. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 1996; 85: 85-90.
63. Hiemenz PC. Principles of colloid and surface chemistry, New York, Marcel Dekker, 1986.
64. Nagarajan R, Ganesh K. Block-copolymer self-assembly in selective solvents: theory of solubilization in spherical micelles. Macromolecules 1989; 22: 4312-25.
65. Nolan SL, Phillips RJ, Cotts PM, Dungan SR. Light scattering study on the effect of polymer composition on the structural properties of PEO-PPO-PEO micelles. J Colloid Interf Sci 1997; 191: 291-302.
66. Yokoyama M, Sugiyama T, Okano T, Sakurai Y, Naito M, Kataoka K. Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm Res 1993; 10: 895-9.
67. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res 1995; 12: 192-5.
68. van Stam J, Creutz S, De Schryver FC, Jerome R. Tuning of the exchange dynamics of unimers between block copolymer micelles with temperature, cosolvents, and cosurfactants. Macromolecules 2000; 33: 6388-95.
69. Jette KK, Law D, Schmitt EA, Kwon GS. Preparation and drug loading of poly(ethylene glycol)-block- poly(ε-caprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharm Res 2004; 21: 1184-91.
70. Adams ML, Kwon GS. The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexyl-Laspartamide)-acyl conjugates. J Biomater Sci Polymer Edn 2002; 13: 991-1006.
71. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Block copolymer micelles for drug delivery: loading and release of doxorubicin. J Control Release 1997; 48: 195-201.
72. Jones MC, Leroux JC. Polymeric micelles: a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999; 48: 101-11.
73. Kwon G, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Control Release 1994; 29: 17-23.
74. Alakhov VY, Moskaleva EY, Batrakova EV, Kabanov AV. Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 copolymer. Bioconjugate Chem 1996; 7: 209-16.
75. Adams ML, Kwon GS. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles:effects of acyl chain length. J Control Release 2003; 87: 23-32.
76. Lavasanifar A, Samuel J, Kwon GS. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and hemolytic activity of amphotericin B. J Control Release 2001; 77: 155-160.
77. Shuai X, Ai H, Nasongkla N, Kim S, Gao J. Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 2004; 98: 415-26.
78. Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, Kataoka K. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release 1998; 55: 219-29.
79. Allen C, Han J, Yu Y, Maysinger D, Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a drug delivery vehicle for dihydrotestosterone. J Control Release 2000; 63: 275-86.
80. Wilhelm M, Zhao C, Wang Y, Xu R, Winnik M, Mura J, Riess G, Croucher M. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study. Macromolecules 1991; 24: 1033-40.
81. Kim J, Domach M, Tiltoni R. Pyrene solubilization capacity in octaethylene glycol monododecyl ether (C12E8) micelles. Colloids Surf A 1999; 150: 55-68.
82. Saito Y, Miura K, Tokuoka, Kondo Y, Abe M, Sato T. Volatility and solubilization of synthetic fragrances by Pluronic P85. J Dispersion Sci Tech 1996; 17:567-76.
83. Nagarajan R, Barry M, Ruckenstein E. Unusual selectivity in solubilization by block copolymer micelles. Langmuir 1986; 2: 210-15.
84. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001; 73: 137-172.
85. Hurter PN, Alexandridis P, Hatton TA. Solubilization in amphiphilic copolymer solutions. Surf Sci Series 1995; 55: 191-235.
86. Yoo HS, Park TG. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release 2001; 70: 63-70.
87. Yasugi K, Nakamura T, Nagasaki Y, Kato M, Kataoka K. Sugar installed polymer micelles: synthesis and micellization of poly(ethylene glycol)-poly(D, L-lactide) block copolymers having sugar groups at the PEG chain end. Macromolecules 1999; 32: 8024-32.
88. Shin IG, Kim SY, Lee YM, Cho CS, Sung YK. Methoxypoly (ethylene glycol)/ ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin: I. Preparation and characterization. J Control Release 1998; 51: 1-11.
89. Burt HM, Zhang X, Toleikin P, Embree L, Hunter WL. Development of copolymers of poly(D, L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloid Surf B 1999; 16: 161-71.
90. Liggins RT, Burt HM. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Del Rev 2002; 54: 191-202.
91. Zhang X, Burt HM, Von Hoff D, Dexter D, Mangold G, Degen D, et al. An investigation of the antitumor activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol 1997; 40: 81-6.
92. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Kim SW, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 2001; 72: 191-202.
93. Nishiyama N, Kataoka K. Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs. In: Advances in experimental medicine and biology, New York, Plenum Publishers, 2003; 155-77.
94. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjugate Chem 2005; 16: 122-30.
95. Bae Y, Fukushima S, Harada A, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed 2003; 42: 4640-3.
96. Li Y, Kwon GS. Methotrexate esters of poly(ethylene oxide)-blockpoly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res 2000; 17: 607-611.
97. Yu BG, Okano T, Kataoka K, Sardari S, Kwon GS. In vitro dissociation and antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(β-benzyl-L-aspartate) micelles. J Control Release 1998; 56: 285-91.
98. Jeong YI, Cheon JB, Kim SH, Nah JW, Lee YM, Sung YK, et al. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release 1998; 51: 169-78.
99. Opanasopit P, Yokoyama M, Watanabe M, Kawano K, Maitani Y, Okano T. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res 2004; 21: 2001-8.
100. Yokoyama M, Opanasopit P, Okano T, Kawano K, Maitani Y. Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J Drug Target 2004; 12: 373-84.
101. Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000; 11: 265-83.
102. Batrakova EV, Li S, Vinogradov V, Alakhov VY, Miller DW, Kabanov AV. Mechanism of Pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 2001; 299: 483-93.
103. Batrakova EV, Li S, Miller DW, Kabanov AV. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 1999; 16: 1366-72.
104. Alakhov V, Klinski E, Li S, Pietrzynski G, Venne A, Batrakova E, et al. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloid Surf B 1999; 16: 113-34.
105. Venne A, Li S, Mandeville R, Kabanov A, Alakhov V. Hypersensitizing effect of Pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res 1996; 56: 3626-9.
106. Danson S, Ferry D, Alakhov V, Margison J, Kerr D, Jowle D, et al. Phase I dose escalation and pharmacokinetic study of Pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 2004; 90: 2085-91.
107. Dwyer C, Viebke C, Meadows J. Propofol induced micelle formation in aqueous block copolymer solutions. Coll Surf A 2005; 254: 23-30.
108. Meadows J, Higginbottom S. Anesthetic formulations of propofol. WO03/ 017977, 2003.
109. Torchilin VP. In: Kabanov AV, Felgner PL, Seymour LW Eds, Self-assembling complexes for gene delivery: from laboratory to clinical trial, New York, Wiley, 1998; 277.
110. Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Adv Drug Del Rev 1995; 16: 195-214.
111. Hawley AE, Davis SS, Illum L. Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev 1995; 17: 129-148.
112. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001; 53: 283-318.
113. Yamamoto Y, Yasugi K, Harada A, Nagasaki Y, Kataoka K. Temperature-related change in the properties relevant to the drug delivery of poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles in aqueous milieu. J Control Release 2002; 82: 359-71.
114. Lavasanifar A, Samuel J, Kwon GS. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide). J Control Release 2002; 79: 165-72.
115. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vasculature permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65: 271-84.
116. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 2001; 46: 149-68.
117. Adams M, Lavasanifar A, Kwon G. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003; 92: 1343-55.
118. Hamaguchi T, Matsumura Y, Suzuki M, Shimizu K, Goda R, Nakamura I, et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer 2005; 92: 1240-6.
119. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 2004; 61: 2549-59.
120. Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kataoka K. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Targeting 1999; 7: 171-86.
121. Nakanishi T, Fukushima S, Okamoto K, Suzuki M, Matsumura Y, Yokoyama M, et al. Development of the polymeric micelle carrier system for doxorubicin. J Control Release 2001; 74: 295-302.
122. Matsumura Y. Phase I clinical trial of nk911, polymer micelle encapsulated doxorubicin. Proceedings of Winter Symp. & 11th Symp. On Recent Advances in Drug Deliv Sys 2003; 55.
123. Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y, Kataoka K. Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichloro-diammineplatinum (II) and poly(ethylene glycol)-poly (α,β-aspartic acid) block copolymer in an aqueous medium. Langmuir 1999; 15: 377-383.
124. Teng Y, Morrison ME, Munk P, Webber SE, Prochaka K. Release kinetics studies of aromatic molecules into water block copolymer micelles. Macromolecules 1998; 31: 3578-87.
125. Su L, Jiang W, Wang A, Guan Z, Pan S. Studies on 5-FU/PEG-PBLG nano-micelles: preparation, characteristics, and drug releasing in vivo. Aizheng 2004; 23: 381-5.
126. Cabral H, Nishiyama N, Okazaki S, Koyama H, Kataoka K. Preparation and biological properties of dichloro(1, 2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. J Control Release 2005; 101: 223-32.
127. Zalipsky S, Harris JM. Poly(ethylene glycol): chemistry and biological applications, Washington D.C., American Chemical Society, 1997; 1-13.
128. Working PK, Newman MS, Johnson J, Cornacoff JB. Safety of poly(ethylene glycol) and poly(ethylene glycol) derivatives. In: Zalipsky S, Harris JM Eds, Poly(ethylene glycol): chemistry and biological applications, Washington D.C., American Chemical Society, 1997; 45-57.
129. Yokoyama M, Okano T. Targetable drug carriers: present status and a future perspective. Adv Drug Deliv Rev 1996; 21: 77-80.
130. Stepanek M, Podhajecka K, Tesarova E, Prochazka K, Tuzar Z, Brown W. Hybrid polymeric micelleswith hydrophobic cores and mixed polyelectrolyte/nonelectrolyte shells in aqueous media. 1. Preparation and basic characterization. Langmuir 2001; 17: 4240-44.
131. Papisov MI. Modeling in vivo transfer of long-circulating polymers (two classes of long circulating polymers and factors affecting their transfer in vivo). Adv Drug Del Rev 1995; 16: 127-39.
132. Jeon SI, Lee JH, Andrade JD, DeGennes PG. Protein-surface interactions in the presence of polyethylene oxide. I. Simplified theory. J Colloid Interf Sci 1991; 142: 149-58.
133. Becher P, Birkmeier RL. The determination of hydrophile-lipophile balance (HLB) by gas-liquid chromatography (GLC). J Am Oil Chem Soc 1964; 41: 169-72.
134. Edens MW. In: Nace VM Ed, Nonionic surfactants: polyoxyalkylene block copolymers, volume 60, New York, Marcel Dekker, Inc., 1996; 186-210.
135. Kabanov AV, Lemieux P, Vinogradov S, Alakhov V. Pluronic block copolymers: novel functional molecules for gene therapy. Adv Drug Deliv Rev 2002; 54: 223-33.
136. Inactive Ingredient Search for Approved Drug Products, "poloxamer", U.S. Food and Drug Administration, 17 April 2005, .
137. Grindel JM, Jaworski T, Piraner O, Emanuele RM, Balasubramanian M. Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. J Pharm Sci 2002; 91: 1936-47.
138. Gibbs WJ, Hagemann TM. Purified poloxamer 188 for sickle cell vaso-occlusive crisis. Ann Pharmacotherapy 2004; 38: 320-4.
139. Kabanov AV, Nazarova IR, Astafieva IV, Batrakova EV, Alakhov YV, Yaraslavov VV, et al. Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules 1995; 28: 2303-14.
140. Miller DW, Batrakova EV, Waltner TO, Alakhov V, Kabanov AV. Interactions of Pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjug Chem 1997; 8: 649-57.
141. Gadelle F, Koros WJ, Schechter RS. Solubilization of aromatic solutes in block copolymers. Macromolecules 1995; 28: 4883-92.
142. Oh KT, Bronich TK, Kabanov AV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J Control Release 2004; 94: 411-22.
143. ε-position in aqueous milieu. Macromolecules 1998; 31: 6071-6.
144. Oh I, Lee K, Kwon HY, Lee YB, Shin SC, Cho CS, et al. Release of adriamycin from poly(gamma-benzyl-glutamate)/poly(ethylene oxide) nanoparticles. Int J Pharm 1999; 181: 107-15.
145. Lee ES, Shin HJ, Na K, Bae YH. Poly(L-histadine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release 2003; 90: 363-74.
146. Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Del Rev 2002; 54: 169-90.
147. Yokoyama M, Okano T, Sakurai Y, Kataoka K. Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Control Release 1994; 32: 269-77.
148. Bolard J, Legrand P, Heitz F, Cybulska B. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 1991; 30: 5707-15.
149. Adams ML, Andes DR, Kwon GS. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. Biomacromolecules 2003; 43: 750-7.
150. Anseth KS, Metters AT, Bryant SJ, Martens PJ, Elisseeff JH, Bowman CN. In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release 2002; 78: 199-209.
151. Wu XS, Wang N. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation. J Biomat Sci Polym E 2001; 12: 21-34.
152. Kim TY, Kim DW, Chung, JY, Shin SG, Kim SC, Heo DS, et al. Phase I and pharmacokinetic study of Genexol-PM, a Cremophorfree, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 2004; 10: 3708-3716.
153. Ikada Y, Tsuji H. Biodegradable polyester for medical and ecological applications. Macromol Rapid Commun 2000; 21: 117-32.
154. Huh KM, Cho YW, Park K. PLGA-PEG block copolymers for drug formulations. Drug Del Tech 2003; 3: 44-9.
155. Barrow WW. Microsphere technology for chemotherapy of mycobacterial infections. Curr Pharm Des 2004; 10(26): 3275-84.
156. Mori T. Cancer-specific ligands identified from screening of peptide-display libraries. Curr Pharm Des 2004; 10(19): 2335-43.
157. Tomioka H. Adjunctive immunotherapy of mycobacterial infections. Curr Pharm Des 2004; 10(26): 3297-312.